Surveillance of antimicrobial use in the hospital sector : a comparison between an Italian and a Chinese reality

Corresponding Author: Antonio SolinAS, MD; e-MAil: SolinAS.Ant@gMAil.coM ABSTRACT: — Objective: The aim of this study was to compare the pattern and general trend of antibiotic consumption during the year 2015 between an Italian and a Chinese hospital to evaluate the variability in the pathogens present and in the resulting inpatient antimicrobial prescriptions. — Methods: This study was carried out at the University Hospital of Sassari (UHS, Sassari, Italy) and at the First Hospital of Qinhuangdao (FHQ, Hebei Province, China) from January to December 2015. The study compares data of antimicrobial consumption, the kind of infections and the number and type of pathogens. — Results: The overall consumption of antimicrobial agents at the UHS was 77.3 DDD/100 bed-days, while at FHQ it was only 40.8 DDD/100 bed-days. At the UHS, Co-amoxiclav was the penicillin most largely used as well as a b-lactamase inhibitor (16.5% of the total). At the FHQ, instead, the most common drugs used were first and second generation cephalosporins (19% of the total). Infections of the respiratory, urinary and gastroenteric tract were the first three most diagnosed infections. The most isolated bacteria type was Escherichia coli for both hospitals (14% of the total). — Conclusions: The study highlights the variation in antimicrobial prescriptions of different geographical regions. The consumption data revealed a conspicuous use of these drugs at the University Hospital of Sassari, which was nearly twice as high than that found at the Chinese hospital. Antimicrobials were prescribed in both hospitals mainly for respiratory tract infections and Escherichia coli was the main cause of infections in both hospitals.

[1]  Fu-Der Wang,et al.  Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[2]  Yonghong Xiao,et al.  Use and prescription of antibiotics in primary health care settings in China. , 2014, JAMA internal medicine.

[3]  F. Song,et al.  A systematic review of antibiotic utilization in China. , 2013, The Journal of antimicrobial chemotherapy.

[4]  Fang Wang,et al.  Overprescribing in China, driven by financial incentives, results in very high use of antibiotics, injections, and corticosteroids. , 2012, Health affairs.

[5]  P. J. van Duijn,et al.  Recent trends in antibiotic resistance in European ICUs , 2011, Current opinion in critical care.

[6]  Dirk Vogelaers,et al.  The rising problem of antimicrobial resistance in the intensive care unit , 2011, Annals of intensive care.

[7]  M. Petzold,et al.  Unnecessary use of antibiotics for inpatient children with pneumonia in two counties of rural China , 2011, International Journal of Clinical Pharmacy.

[8]  J. Wang,et al.  Bacterial resistance surveillance in China: a report from Mohnarin 2004–2005 , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[9]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship , 2007 .

[10]  W. Seto,et al.  Optimising antimicrobial prescription in hospitals by introducing an antimicrobial stewardship programme in Hong Kong: consensus statement. , 2006, Hong Kong medical journal = Xianggang yi xue za zhi.

[11]  H. Goossens,et al.  Outpatient antibiotic use in Europe and association with resistance: a cross-national database study , 2005, The Lancet.

[12]  G. Fraser,et al.  Antimicrobial Stewardship Programs as a Means to Optimize Antimicrobial Use Insights from the Society of Infectious Diseases Pharmacists , 2004, Pharmacotherapy.

[13]  M. Struelens The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions , 1998, BMJ.

[14]  R. Moellering,et al.  Antimicrobial-drug resistance. , 1996, The New England journal of medicine.

[15]  P. Gastmeier,et al.  ResearchDramatic increase of third-generation cephalosporin-resistant E . coli in German intensive care units : secular trends in antibiotic drug use and bacterial resistance , 2001 to 2008 , 2010 .

[16]  Hao Feng-lan Mohnarin Bacterial Resistance Surveillance 2006-2007 , 2008 .